CY1122419T1 - Εξανθρωπισμενοι ποντικοι οι οποιοι εκφραζουν βαριες αλυσιδες που περιεχουν τομεις vl - Google Patents

Εξανθρωπισμενοι ποντικοι οι οποιοι εκφραζουν βαριες αλυσιδες που περιεχουν τομεις vl

Info

Publication number
CY1122419T1
CY1122419T1 CY20191101302T CY191101302T CY1122419T1 CY 1122419 T1 CY1122419 T1 CY 1122419T1 CY 20191101302 T CY20191101302 T CY 20191101302T CY 191101302 T CY191101302 T CY 191101302T CY 1122419 T1 CY1122419 T1 CY 1122419T1
Authority
CY
Cyprus
Prior art keywords
heavy chain
human
light chain
human immunoglobulin
dehumanized
Prior art date
Application number
CY20191101302T
Other languages
English (en)
Inventor
Lynn Macdonald
Cagan Gurer
Karolina A. MEAGHER
Sean Stevens
Andrew J. Murphy
Original Assignee
Regeneron Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharmaceuticals, Inc. filed Critical Regeneron Pharmaceuticals, Inc.
Publication of CY1122419T1 publication Critical patent/CY1122419T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C07K16/462—Igs containing a variable region (Fv) from one specie and a constant region (Fc) from another
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Humanized animals, e.g. knockin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24046—Adamalysin (3.4.24.46)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/53—Hinge
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/64—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a combination of variable region and constant region components
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2318/00—Antibody mimetics or scaffolds
    • C07K2318/10—Immunoglobulin or domain(s) thereof as scaffolds for inserted non-Ig peptide sequences, e.g. for vaccination purposes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/20—Pseudochromosomes, minichrosomosomes
    • C12N2800/204—Pseudochromosomes, minichrosomosomes of bacterial origin, e.g. BAC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Abstract

Παρέχονται ζώα πλην του ανθρώπου, μη ανθρώπινοι ιστοί, κύτταρα και γενετικό υλικό που περιλαμβάνουν μια τροποποίηση μιας ενδογενούς μη ανθρώπινης αλληλουχίας βαριάς αλυσίδας της ανοσοσφαιρίνης και που περιλαμβάνουν δράση ADAM6 που είναι λειτουργική σε ένα τρωκτικό (π.χ. έναν ποντικό), όπου τα ζώα πλην του ανθρώπου αναδιατάσσουν ανθρώπινα γονιδιακά τμήματα ελαφριάς αλυσίδας της ανοσοσφαιρίνης στο πλαίσιο σταθερών περιοχών βαριάς αλυσίδας και εκφράζουν μόρια ομοιάζοντα με ανοσοσφαιρίνη που περιλαμβάνουν ανθρώπινους μεταβλητούς τομείς ελαφριάς αλυσίδας της ανοσοσφαιρίνης συντετηγμένους με σταθερούς τομείς βαριάς αλυσίδας που είναι συγγενείς με ανθρώπινους μεταβλητούς τομείς ελαφριάς αλυσίδας της ανοσοσφαιρίνης συντετηγμένους με σταθερούς τομείς ελαφριάς αλυσίδας.
CY20191101302T 2012-02-01 2019-12-10 Εξανθρωπισμενοι ποντικοι οι οποιοι εκφραζουν βαριες αλυσιδες που περιεχουν τομεις vl CY1122419T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261593463P 2012-02-01 2012-02-01
US201261677538P 2012-07-31 2012-07-31
PCT/US2013/024295 WO2013116609A1 (en) 2012-02-01 2013-02-01 Humanized rodents that express heavy chains containing vl domains

Publications (1)

Publication Number Publication Date
CY1122419T1 true CY1122419T1 (el) 2021-01-27

Family

ID=47714588

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20191101302T CY1122419T1 (el) 2012-02-01 2019-12-10 Εξανθρωπισμενοι ποντικοι οι οποιοι εκφραζουν βαριες αλυσιδες που περιεχουν τομεις vl
CY20211100659T CY1124361T1 (el) 2012-02-01 2021-07-20 Εξανθρωπισμενα τρωκτικα που εκφραζουν βαριες αλυσιδες που περιεχουν τομεις vl

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20211100659T CY1124361T1 (el) 2012-02-01 2021-07-20 Εξανθρωπισμενα τρωκτικα που εκφραζουν βαριες αλυσιδες που περιεχουν τομεις vl

Country Status (26)

Country Link
US (3) US20130212719A1 (el)
EP (3) EP3912465A1 (el)
JP (6) JP2015505477A (el)
KR (2) KR20140123983A (el)
CN (2) CN106117364B (el)
AU (3) AU2013204758B2 (el)
BR (1) BR112014018843B1 (el)
CA (1) CA2863175A1 (el)
CY (2) CY1122419T1 (el)
DK (2) DK2809150T3 (el)
ES (2) ES2753774T3 (el)
HK (1) HK1202771A1 (el)
HR (2) HRP20192218T1 (el)
HU (2) HUE055610T2 (el)
IL (3) IL233827A0 (el)
LT (2) LT2809150T (el)
ME (1) ME03611B (el)
MX (2) MX2020003491A (el)
NZ (3) NZ627977A (el)
PL (2) PL2809150T3 (el)
PT (2) PT3597038T (el)
RS (2) RS59699B1 (el)
RU (2) RU2664185C2 (el)
SG (3) SG10201913428QA (el)
SI (2) SI2809150T1 (el)
WO (1) WO2013116609A1 (el)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2436044T3 (es) * 2008-05-23 2013-12-26 Ablexis, Llc Procedimiento de generación de anticuerpos de dominio VL individual en animales transgénicos
US9445581B2 (en) 2012-03-28 2016-09-20 Kymab Limited Animal models and therapeutic molecules
US20120204278A1 (en) 2009-07-08 2012-08-09 Kymab Limited Animal models and therapeutic molecules
ES2965212T3 (es) 2009-07-08 2024-04-11 Kymab Ltd Modelos de animales y moléculas terapéuticas
NZ707327A (en) 2010-08-02 2017-01-27 Regeneron Pharma Mice that make binding proteins comprising vl domains
ES2872081T3 (es) 2011-08-05 2021-11-02 Regeneron Pharma Ratones con cadena ligera universal humanizada
CA2846322A1 (en) 2011-09-19 2013-03-28 Kymab Limited Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
WO2013045916A1 (en) 2011-09-26 2013-04-04 Kymab Limited Chimaeric surrogate light chains (slc) comprising human vpreb
GB201122047D0 (en) * 2011-12-21 2012-02-01 Kymab Ltd Transgenic animals
US9253965B2 (en) 2012-03-28 2016-02-09 Kymab Limited Animal models and therapeutic molecules
MX356429B (es) 2011-12-20 2018-05-29 Regeneron Pharma Ratones con cadena ligera humanizada.
DK2809150T3 (da) * 2012-02-01 2019-12-09 Regeneron Pharma Humaniserede mus, der udtrykker tungkæder indeholdende VL-domæner
US10251377B2 (en) 2012-03-28 2019-04-09 Kymab Limited Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies
GB2502127A (en) 2012-05-17 2013-11-20 Kymab Ltd Multivalent antibodies and in vivo methods for their production
LT3597037T (lt) 2012-06-12 2021-06-10 Regeneron Pharmaceuticals, Inc. Humanizuoti gyvūnai, išskyrus žmones, su apribotu imunoglobulino sunkiosios grandinės lokusu
RS57582B1 (sr) 2013-02-20 2018-11-30 Regeneron Pharma Nehumane životinje sa modifikovanim sekvencama imunoglobulinskog teškog lanca
US9788534B2 (en) 2013-03-18 2017-10-17 Kymab Limited Animal models and therapeutic molecules
US9783618B2 (en) 2013-05-01 2017-10-10 Kymab Limited Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
US11707056B2 (en) 2013-05-02 2023-07-25 Kymab Limited Animals, repertoires and methods
US9783593B2 (en) 2013-05-02 2017-10-10 Kymab Limited Antibodies, variable domains and chains tailored for human use
JP7133902B2 (ja) 2013-10-01 2022-09-09 カイマブ・リミテッド 動物モデル及び治療用分子
JP2017510273A (ja) 2014-03-21 2017-04-13 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 異なる結合特性を示すｖｌ抗原結合タンパク質
KR20210088756A (ko) 2014-03-21 2021-07-14 리제너론 파마슈티칼스 인코포레이티드 단일 도메인 결합 단백질을 생산하는 비-인간 동물
AU2016232715A1 (en) * 2015-03-19 2017-09-28 Regeneron Pharmaceuticals, Inc. Non-human animals that select for light chain variable regions that bind antigen
ES2959608T3 (es) * 2015-04-03 2024-02-27 Dana Farber Cancer Inst Inc Composición y métodos de edición del genoma de células B
KR20240016444A (ko) 2016-05-20 2024-02-06 리제너론 파마슈티칼스 인코포레이티드 다중 가이드 RNAs를 이용한 면역학적 내성 파괴 방법
CN110719732B (zh) * 2017-03-30 2022-11-18 犹他州立大学 表达蜘蛛丝的转基因蚕
HUE060608T2 (hu) * 2017-12-05 2023-03-28 Regeneron Pharma Genetikailag módosított immunglobulin lambda könnyûlánccal rendelkezõ egerek és azok alkalmazása
RU2020131383A (ru) * 2018-03-24 2022-04-26 Ридженерон Фармасьютикалз, Инк. Генетически модифицированные животные, отличные от человека, для выработки терапевтических антител против комплексов пептид-mhc, способы их получения и варианты применения
SG11202012084WA (en) * 2018-06-14 2021-01-28 Regeneron Pharma Non-human animals capable of dh-dh rearrangement in the immunoglobulin heavy chain coding sequences
US20220090060A1 (en) 2020-09-11 2022-03-24 Regeneron Pharmaceuticals, Inc. Identification and production of antigen-specific antibodies
EP4262373A1 (en) 2020-12-16 2023-10-25 Regeneron Pharmaceuticals, Inc. Mice expressing humanized fc alpha receptors
CN114645042A (zh) * 2020-12-18 2022-06-21 中国食品药品检定研究院 一种构建具有表达荧光素酶和红色荧光蛋白的重组巨噬细胞的转基因小鼠的方法
CN114196626A (zh) * 2022-02-16 2022-03-18 北京国卫生物科技有限公司 脐带间充质干细胞及其分离培养扩增方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774279B2 (en) 1997-05-30 2004-08-10 Carnegie Institution Of Washington Use of FLP recombinase in mice
CA2634294A1 (en) * 2000-08-03 2002-02-14 Therapeutic Human Polyclonals, Inc. Production of humanized antibodies in transgenic animals
US6596541B2 (en) * 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7105348B2 (en) 2000-10-31 2006-09-12 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
CN101016543A (zh) * 2000-11-17 2007-08-15 罗切斯特大学 筛选编码抗原特异性免疫球蛋白分子或其抗原特异性片段的多核苷酸的方法
US7473557B2 (en) 2001-06-06 2009-01-06 Regeneron Pharmaceuticals, Inc. Method for targeting transcriptionally active loci
WO2003081993A2 (en) * 2002-03-22 2003-10-09 Origen Therapeutics Transgenic aves producing human polyclonal antibodies
MXPA06000562A (es) * 2003-07-15 2006-03-30 Therapeutic Human Polyclonals Loci de inmunoglobulina humanizada.
WO2006044962A1 (en) 2004-10-19 2006-04-27 Regeneron Pharmaceuticals, Inc. Method for generating an animal homozygous for a genetic modification
US20080184380A1 (en) * 2004-10-22 2008-07-31 Therapeutic Human Polyclonals Inc. Suppression of Endogenous Immunoglobulin Expression in Non-Human Transgenic Animals
JP5514539B2 (ja) * 2006-03-31 2014-06-04 メダレックス・リミテッド・ライアビリティ・カンパニー ヒト抗体の調製に用いるためのキメラ抗体を発現するトランスジェニック動物
EP2064325B1 (en) * 2006-09-01 2011-12-07 Therapeutic Human Polyclonals, Inc. Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals
WO2009026660A1 (en) * 2007-08-30 2009-03-05 Walter And Eliza Hall Institute Of Medical Research Dendritic cell marker and uses thereof
SG10201605394SA (en) * 2007-09-26 2016-08-30 Chugai Pharmaceutical Co Ltd Modified Antibody Constant Region
US7659842B2 (en) 2007-10-24 2010-02-09 Infineon Technologies Ag Quantization error reduction in PWM full-MASH converters
ES2436044T3 (es) * 2008-05-23 2013-12-26 Ablexis, Llc Procedimiento de generación de anticuerpos de dominio VL individual en animales transgénicos
EP2556747B1 (en) * 2008-06-27 2020-12-02 Merus N.V. Antibody producing transgenic mice
BRPI0917352A2 (pt) * 2008-08-29 2017-08-22 Symphogen As Métodos para produção de uma biblioteca de pares cognatos que compreende sequências ligadas que codificam regiões variáveis e para gerar um vetor que codifica um anticorpo quimérico com regiões de seres humanos constantes e regiões variáveis não humanas, biblioteca de vetores, e método para produção de uma biblioteca de sequências de imunoglobulina derivadas de aves
US9085795B2 (en) * 2009-02-04 2015-07-21 Molecular Innovations, Inc. Methods for screening candidate agents for modulating prorenin and renin, assays for detecting prorenin and antibodies
US20120204278A1 (en) * 2009-07-08 2012-08-09 Kymab Limited Animal models and therapeutic molecules
ES2965212T3 (es) * 2009-07-08 2024-04-11 Kymab Ltd Modelos de animales y moléculas terapéuticas
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей
EP2582230A1 (en) * 2010-06-17 2013-04-24 Kymab Limited Animal models and therapeutic molecules
NZ707327A (en) * 2010-08-02 2017-01-27 Regeneron Pharma Mice that make binding proteins comprising vl domains
DK2550363T3 (en) * 2011-02-25 2015-03-23 Regeneron Pharma ADAM6 mice
ES2872081T3 (es) * 2011-08-05 2021-11-02 Regeneron Pharma Ratones con cadena ligera universal humanizada
MX356429B (es) * 2011-12-20 2018-05-29 Regeneron Pharma Ratones con cadena ligera humanizada.
DK2809150T3 (da) * 2012-02-01 2019-12-09 Regeneron Pharma Humaniserede mus, der udtrykker tungkæder indeholdende VL-domæner
LT3597037T (lt) * 2012-06-12 2021-06-10 Regeneron Pharmaceuticals, Inc. Humanizuoti gyvūnai, išskyrus žmones, su apribotu imunoglobulino sunkiosios grandinės lokusu
LT3407709T (lt) * 2016-11-04 2020-10-12 Regeneron Pharmaceuticals, Inc. Gyvūnai, išskyrus žmogų, turintys sukonstruotą imunoglobulino lambda lengvosios grandinės lokusą

Also Published As

Publication number Publication date
HRP20192218T1 (hr) 2020-03-06
CY1124361T1 (el) 2022-07-22
JP2023014242A (ja) 2023-01-26
BR112014018843A2 (pt) 2017-07-04
US20210368751A1 (en) 2021-12-02
AU2013204758A1 (en) 2013-08-15
JP2019170395A (ja) 2019-10-10
CN104202971A (zh) 2014-12-10
PT3597038T (pt) 2021-05-10
AU2015246154B2 (en) 2017-11-23
HUE055610T2 (hu) 2021-12-28
AU2013204758B2 (en) 2015-07-23
JP6942757B2 (ja) 2021-09-29
SI2809150T1 (sl) 2019-11-29
SG10201606256TA (en) 2016-09-29
LT3597038T (lt) 2021-05-25
JP2023168590A (ja) 2023-11-24
US20170094955A1 (en) 2017-04-06
DK3597038T3 (da) 2021-06-28
PT2809150T (pt) 2019-12-09
AU2017251848B2 (en) 2020-02-20
MX2020003491A (es) 2022-10-25
CN106117364B (zh) 2021-08-31
SG10201913428QA (en) 2020-03-30
MX2019002517A (es) 2019-06-17
RU2014133653A (ru) 2016-03-20
IL268675B (en) 2020-11-30
NZ719228A (en) 2022-08-26
AU2017251848A1 (en) 2017-11-16
HRP20210987T1 (hr) 2021-09-17
PL2809150T3 (pl) 2020-04-30
EP2809150B1 (en) 2019-09-18
IL268675A (en) 2019-10-31
RU2770016C2 (ru) 2022-04-14
LT2809150T (lt) 2019-10-25
JP7187615B2 (ja) 2022-12-12
CN106117364A (zh) 2016-11-16
PL3597038T3 (pl) 2021-11-08
NZ627977A (en) 2016-06-24
AU2015246154A1 (en) 2015-11-12
BR112014018843B1 (pt) 2024-02-20
JP2015505477A (ja) 2015-02-23
RU2018122695A3 (el) 2021-10-06
RS62023B1 (sr) 2021-07-30
US20130212719A1 (en) 2013-08-15
WO2013116609A1 (en) 2013-08-08
NZ734504A (en) 2022-10-28
KR20140123983A (ko) 2014-10-23
BR112014018843A8 (pt) 2019-01-29
HK1202771A1 (en) 2015-10-09
IL261280A (en) 2018-10-31
SI3597038T1 (sl) 2021-07-30
RU2664185C2 (ru) 2018-08-15
ME03611B (me) 2020-07-20
DK2809150T3 (da) 2019-12-09
EP2809150A1 (en) 2014-12-10
JP2018075041A (ja) 2018-05-17
ES2870703T3 (es) 2021-10-27
CA2863175A1 (en) 2013-08-08
ES2753774T3 (es) 2020-04-14
IL233827A0 (en) 2014-09-30
JP2021137030A (ja) 2021-09-16
IL261280B (en) 2019-08-29
CN104202971B (zh) 2016-07-06
EP3597038B1 (en) 2021-04-21
HUE046744T2 (hu) 2020-03-30
SG11201404477YA (en) 2014-08-28
KR20190006029A (ko) 2019-01-16
JP6698718B2 (ja) 2020-05-27
RU2018122695A (ru) 2019-03-06
EP3912465A1 (en) 2021-11-24
EP3597038A1 (en) 2020-01-22
RS59699B1 (sr) 2020-01-31

Similar Documents

Publication Publication Date Title
CY1122419T1 (el) Εξανθρωπισμενοι ποντικοι οι οποιοι εκφραζουν βαριες αλυσιδες που περιεχουν τομεις vl
CY1121638T1 (el) Ποντικοι με εξανθρωπισμενη ελαφρια αλυσιδα
CY1124320T1 (el) Ανθρωποποιημενα μη ανθρωπινα ζωα με περιορισμενους τοπους βαριας αλυσιδας ανοσοσφαιρινης
CY1122091T1 (el) Μορια δεσμευσης-cd37 και ανοσοσυζευγματα εξ αυτων
CY1121608T1 (el) Ποντικια που δημιουργουν αντισωματα βαριας αλυσιδας
CY1122940T1 (el) Μη ανθρωπινα ζωα που εχουν ενα εξανθρωπισμενο γονιδιο προγραμματισμενου κυτταρικου θανατου 1
CY1122205T1 (el) Ποντικοι adam6
CY1124972T1 (el) Ποντικοι με περιορισμενη βαρια αλυσιδα ανοσοσφαιρινης
CY1119071T1 (el) Εξανθρωποποιημενα il-7 τρωκτικα
CY1122409T1 (el) Σχεδιασμος σταθερου ετεροδιμερικου αντισωματος με μεταλαξεις στην επικρατεια fc
CY1121864T1 (el) Τρωκτικα που εκφραζουν ευαισθητες στο ρη αλληλουχιες ανοσοσφαιρινης
CY1123215T1 (el) Πολυνουκλεοτιδια τα οποια κωδικοποιουν αντισωματα τρωκτικων με ανθρωπινους ιδιοτυπους και ζωα τα οποια διαθετουν αυτα
CY1120626T1 (el) Αντισωματα και αλλα μορια που δεσμευουν β7-η1 και pd-1
CY1124358T1 (el) Ευκολως απομονωμενα διειδικα αντισωματα με φυσικης ανοσοσφαιρινης μορφη
CY1124605T1 (el) Ζωα με εξανθρωπισμενα il-4 και il-4r αλφα
CY1119510T1 (el) Συνδυασμος dr5 αγωνιστη και anti-pd1 ανταγωνιστη και μεθοδοι χρησης
CY1121545T1 (el) Ποντικοι που εκφραζουν περιορισμενο ρεπερτοριο ελαφριων αλυσιδων ανοσοσφαιρινης
CY1120945T1 (el) Γενετικως τροποποιημενοι ποντικοι υποδοχεα τ κυτταρων
CY1118259T1 (el) Μεθοδος αναλυσης μεθυλιωσης
BR112016021572A2 (pt) Métodos para preparar um animal não humano geneticamente modificado e para produzir proteínas de ligação, hibridoma, ácido nucleico, célula, e, proteína de ligação
CY1116823T1 (el) Στοχευση abcb5 για θεραπεια καρκινου
UY34372A (es) Moléculas de ácido nucleico que se dirigen a rpa70 y confieren resistencia a plagas de coleópteros.
MX363022B (es) Roedores humanizados que expresan cadenas pesadas que contienen dominios vl.
Martin Re-thinking our professional identity in light of new responsibilities
Hsieh The differences in English learning belief between young and elderly learners